PTO/'AiA/lB (10-17)
`Approved for use through 11/30/2017. OMB 0651- 0032
`U‘1 .F‘atent and ‘i'rao'emark Office; U.S. DEF/aii'rl‘flEN'r Oi: (.Oi‘v’iMi:RCE
`Under the Paperwork Reduction Act of L995 no persons are required to respond to a cciiecticn on information uniess it displays a vaiio‘ OMB contra! number.
`11111111 '4$7697709201
`FATENT APPLECATiQN
`F’mm'mj’”""”"" $Tim0thy A- BEaUWkamF-i at al-
`(Oniyfar new nonprovisional appiications under 37 CFR 1.53113”
`
`Priority Mail Express®
`Label No.
`
`,
`EFF-”ed
`
`TRANEMEWAL SAMPLE PREP/KRADON MEFHODS, SYSTEMS AND COMPOSiIIONS
`
`.
`
`APPLECA‘E‘EQN ELEMEN'E'S
`See MPEP chapter 600 concerning utility patent application contents.
`
`ADDRESS T0:
`
`Commissioner for Patents
`13.0. 3113‘ 1450
`Aiexandria, VA 22313—14561
`
`1Il:l Fee Transmittal mm
`(PTO/SBA? or equivalent]
`
`ACCGMPANWNG APPLECAiiGN PAPERS
`
`2. [—1 Appiicant asserts smaii entity status.
`""" See 37 021(127
`
`10‘ 1
`
`Assignment i’apers
`(cover sheet 8. documentisi)
`
`
`3. D Appiicant certifies micro entity status. See .37 CFR 21,9,
`Appiicant must attach.o1m .—“',TO/S Ei/ISL313. or E101 equivalent.
`
`Name at Assignee ---------------------------------------------------------
`_______________________________________________________________________________________
`
`]
`
`11.
`
`37 CFR 3.73M Statement
`(when there is an aswgnee)
`
`E i’ower of Attorney
`
`1,.
`
`1311111
`
`[Total Pages 111
`4. [7] Specification
`Both the claims and abstract must start on a new page,
`(See MPEP 9' 603.01 {11),er information on the preferred arrangement)
`5. [Z] Drawingis} (35 use 1131
`{Total Sheets 39____________________1
`ES.
`inventor’s Oath or Declaration
`{Total Pages
`(including substitute statements under 37 CFR 1.64 and ass
`serving as an oath or r/eciamrion unde.'37 CFR 163(9),)
`a.
`mNewly executed!Ioriginai or com)
`i A copy from a prior application (37 CFR 16301))
`Appiicaiion Data Sheet
`* See note below.
`See 37 CFR 1.761PTO/AIA/14 or equivalent)
`C9~RQM or CD41
`ad”.
`.1
`.
`.2,
`.M , m,
`in duphcate, ia1ge table, 0. compoter Program ‘Apan IX,
`E Landsca 2e Table or: CD
`9. Nucieotide anti/or Amino Acid Sequence Submission
`(if applicable. items a.
`c. are required)
`a. 1
`Computer Readable Form (CRF‘;
`1.3
`111:1 Specification Sequence Listing on:
`iCD-ROMG. CDR’7ccp1.s,: or
`ii.l:| Paper
`
`c. m Statements verifying identity of above cor. --
`11p.
`*Note:
`)Benefit c'aims under 37 CFR 1.78, and foreign priority claims under 1 55 must be included in an Application Data Sheet (ADS).
`(2
`)For applications filed 1111119175115 C 111, the application must contain an ADS spa. .r.ying the applicant if the applicant is an
`a:signee, pe1son to whom the inventoris under a1'oiigation to assign, or person who otherwise shows sufficient proprietary
`intLerest in the matter. See 37 CFR 1 46(12)
`19. CGRRESEGNDENCE ADDRESS
`
`English Transiation Document
`(ifapplicoble)
`13.
`information Disciosure Statement
` (PTO/SB/OS or PTO»1449}
`El Copies of citations attached
`Preliminary Amendment
`Return Receipt Postcard
`(MPEP § 503‘) (Should be specifically itemized)
`
`b.
`
`
`
`8.
`
`’Ln
`
`p..
`
`,
`
`-----1
`,.
`
`15. J Certified Copy of Priority Documentisi
`1]foreign priority is claimed)
`..
`1’,‘ :l Nonpubiication Request
`Under .3511S.C.122(h1(21131.1). Applicant m-istattach foam PTG/SB/3S
`o1 equivalent.
`
`18.
`
`1:1
`
`Other:
`
`
`
`
`..............................................................................................
`
`
`
`
`
`ess associated with Customer Number: 021971
`
`DR U Correspondence acidpress below
`
`
`
`
`——
`
`iRaohana Komari
`
`0442—2018
`
`"
`
`s to file (and by the USPTO
`redby 37 CFR‘ .153,‘I The information'is required to obtain or retaina hen it by the pubiir. wh
`ion of inforn tion is rea
`This coile
`
`
`to process: an application. Confide..tiaii
`govemed'by 35 U. S. C. 122 and 37 CFR 1.1.1 andi14. This collectionis estimated to talI:L 12 minuth to complete,
`i..ciuding gat..ering, perari..g, and sub...itti..gIthe compiLtLd appiicatiorI 101.in to thL USPTO. Time wiil vaw depending upon the individuai c;se. Any comments on
`
`the amOIInt of time you requiie to compiete this form and/or suggestions for reducing this burdm, shouid be sent to the Chief information Officer, 115 Patent and
`Trademark Office, U.S. Department of Commerce. PO. Box 1450,1’xiexandria. VA 22313-1450. DO NOT SEND FEES 0P. COMPLETED FORMS T0 TiiiS ADDRESS. SEND
`T0: Commissioner for Patents, 13.0. Eiox 145G, Aiexandria, VA 22313-1450.
`lfyou need assistance in completing thefarm, mil 1-800—1”T0—9199 and select option 2.
`
`
`
`
`
`

`

`Privacy Act Statement
`
`The Privacy Act of 13% {P.L. 93—5”) requires that you be given certain information in connection with your
`submission of the attached form retated to a patent appiicaticn or patent. Accordingty, pursuant to the
`requirements or the Act, ptease be advised that: (t) the generat authority for the coltection of this information is
`35 USE. 233(2); (2) furnishing of the information soiicited is votuntary; and (3) the principai purpose for which
`the information is used by the US. Patent and Trademark Office is to process and/or examine your submission
`related to a patent appiication or patent.
`it you do not furnish the requested int‘ormation, the US. Patent and
`Trademark Office may not be able to process and/or examine your submission, which may resutt in termination
`of proceedings or abandonment ot the appiicaticn or expiration otthe patent.
`
`The information provided by you in this form witi be subject to the foitowing routine uses:
`
`1 . The information on this form wiit be treated confidentiaiiy to the extent allowed under the Freedom of
`information Act (5 USC. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of
`records may be disctosed to the Department of Justice to determine whether disciosure of these
`records is required by the Freedom ot information Act.
`A record from this system of records may be disciosed, as a routine use, in the course of presenting
`evidence to a court, magistrate, or administrative tribunat, inciuding disciosures to opposing counsei in
`the course of setttement negotiations.
`A record in this system of records may be disciosed, as a routine use, to a Member of Congress
`submitting a request involving an individuai, to whom the record pertains, when the individuat has
`requested assistance from the Member with respect to the subject matter otthe record.
`A record in this system of records may be disciosed, as a routine use. to a contractor of the Agency
`having need for the information in order to perform a contract. Recipients of information shait be
`required to compiy with the requirements of the Privacy Act of1974, as amended, pursuant to 5 use.
`552arm).
`A record reiated to an tnternationat Appiication tited under the Patent Cooperation Treaty in this
`system of records may be disctosed, as a routine use,
`to the international Bureau of the Wortd
`lntetiectuat Property Qrganization, pursuant to the Patent Cooperation Treaty.
`A record in this system oi records may be disclosed, as a routine use, to another tederai agency for
`purposes of Nationai $ecurity review (35 USS. tBt) and for review pursuant to the Atomic Energy Act
`(42 USS. 218(c».
`A record from this system of records may be disciosed, as a routine use, to the Administrator, Generai
`Services, or his/her designee, during an inspection of records conducted by GSA as part of that
`agency’s responsibility to recommend improvements in records management practices and programs,
`under authority of 44 U33. 2904 and 2906. Such disctosure shait be made in accordance with the
`GSA reguiations governing inspection at records tor this purpose, and any other reievant (to, (38A or
`Commerce) directive. Such disciosure shaii not be used to make determinations about individuais.
`A record from this system of records may be disoiosed, as a routine use, to the puhiic after either
`pubiication ot the appiication pursuant to 35 U.S.C.
`t22tb) or issuance of a patent pursuant to 35
`USC. 151. Further, a record may he disciosed, subject to the iimitations of 37 CFR 1.14, as a routine
`use, to the pubiio it the record was tiied in an appiication which became abandoned or in which the
`proceedings were terminated and which appiicaticn is referenced by either a pubiished application, an
`appiicaticn open to pubtic inspection or an issued patent.
`A record from this system of records may be disciosed, as a routine use, to a Federai, State, or tocat
`iaw enforcement agency,
`if the USPTO becomes aware of a vioiation or potential vioiation of iaw or
`reguiation.
`
`